Cargando…

Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene

Alcohol use disorder is a major public health issue. The absolute mortality burden of alcohol-attributable death has increased over the last 20 years. However, access to care remains very poor and many people with alcohol use disorder are untreated. The main limiting factor for access to care in alc...

Descripción completa

Detalles Bibliográficos
Autores principales: Luquiens, Amandine, Aubin, Henri-Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189699/
https://www.ncbi.nlm.nih.gov/pubmed/25302021
http://dx.doi.org/10.2147/PPA.S57358
_version_ 1782338402632335360
author Luquiens, Amandine
Aubin, Henri-Jean
author_facet Luquiens, Amandine
Aubin, Henri-Jean
author_sort Luquiens, Amandine
collection PubMed
description Alcohol use disorder is a major public health issue. The absolute mortality burden of alcohol-attributable death has increased over the last 20 years. However, access to care remains very poor and many people with alcohol use disorder are untreated. The main limiting factor for access to care in alcohol use disorder appears to be the reluctance to engage in abstinence. Risk reduction is a developing approach in the treatment of alcohol use disorders, drawing its inspiration, with quite a delay, from the decades-long dominant approach in other substance use disorders. A paradigm shift has recently occurred that places more of an emphasis on reducing alcohol as a therapeutic strategy for patients with alcohol use disorder, to better meet the patients’ preferences and needs. The development and recent approval of nalmefene, in alcohol-dependent adults with a high drinking risk level, contributes to enlarging the therapeutic arsenal for alcohol dependence, strengthening the legitimacy of alcohol reduction strategies.
format Online
Article
Text
id pubmed-4189699
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41896992014-10-09 Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene Luquiens, Amandine Aubin, Henri-Jean Patient Prefer Adherence Review Alcohol use disorder is a major public health issue. The absolute mortality burden of alcohol-attributable death has increased over the last 20 years. However, access to care remains very poor and many people with alcohol use disorder are untreated. The main limiting factor for access to care in alcohol use disorder appears to be the reluctance to engage in abstinence. Risk reduction is a developing approach in the treatment of alcohol use disorders, drawing its inspiration, with quite a delay, from the decades-long dominant approach in other substance use disorders. A paradigm shift has recently occurred that places more of an emphasis on reducing alcohol as a therapeutic strategy for patients with alcohol use disorder, to better meet the patients’ preferences and needs. The development and recent approval of nalmefene, in alcohol-dependent adults with a high drinking risk level, contributes to enlarging the therapeutic arsenal for alcohol dependence, strengthening the legitimacy of alcohol reduction strategies. Dove Medical Press 2014-09-29 /pmc/articles/PMC4189699/ /pubmed/25302021 http://dx.doi.org/10.2147/PPA.S57358 Text en © 2014 Luquiens and Aubin. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Luquiens, Amandine
Aubin, Henri-Jean
Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
title Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
title_full Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
title_fullStr Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
title_full_unstemmed Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
title_short Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
title_sort patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189699/
https://www.ncbi.nlm.nih.gov/pubmed/25302021
http://dx.doi.org/10.2147/PPA.S57358
work_keys_str_mv AT luquiensamandine patientpreferencesandperspectivesregardingreducingalcoholconsumptionroleofnalmefene
AT aubinhenrijean patientpreferencesandperspectivesregardingreducingalcoholconsumptionroleofnalmefene